Crinetics Pharmaceuticals, Inc.
XNAS:CRNX
54.95
$62.95 - 100.00
$50.26 - 100.00
$54.09
$56.7
$55.56
$55.41
57.99
24.1
1114233
1252365.5
95192335.66
Chart
TendieTensor AI Analysis
Company
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.
Fundamentals
437
-12.120000
4.845700
100
BBG00BC59224
BBG00BC592C3
94.18M
94.89M
Technicals
Short Interest
—
—
—
Higher = harder to cover
—
Prev: —
—
—
5D avg: —
—
Discussion
Login to participate in discussions.
Recent News
Related Stocks
Based on the portfolios of people who own CRNX. This is a list generated by trading data from 3rd party trading platforms, and it's not a recommendation.